Spotlight on CDER Science
Pharmacodynamic Biomarkers: Their Role in Biosimilar Product Development
A biosimilar product (biosimilar) is highly similar to, and has no clinically meaningful differences from, an FDA-approved reference product. Biosimilars may spur competition and result in additional safe, effective, and affordable biological product (biologic) treatments.